Immunotherapy for AML – OncLive – Immunotherapy Today

Posted by btwatson on February 26, 2019 7:00 pm
Tags:
Categories: Crispr Articles

</div> </div> <p class="home-link"><a href="https://immunotherapytoday.com">< Immunotherapy Today home</a></p> </div> <div id="sidebar-col" class="single-sidebar"> <div class="widget-box drudge_col_gnews" id="drudge-column-gnews-3">  <div class="wpd-gnews-links"><h2 class="widget-head">Immunotherapy News</h2> <ul class="gnews-links posts-list"> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNbmNEVkR6TGx2T0JudUtvN0c1UkJRMldhNFJRT2s2ajR4aFJSQW85UnB1cFZiSUlIdTk0M1VlTGd0Yk5wVFhLZGFQaklObW1kRUJkX3BheE5lQVpxVWROMWt1Vm5nTjV5TEFWNTc4RTc5RUQ1SUtQRm9BSnFINGdOVWZxRHd2a3hnTEYzdy10YjRKMk9MZmN4SzM5SGY3SHZBT040OWNOSjVRX0pESXYxQVZaT0c?oc=5" class="headline-link">Tumor splicing burden predicts treatment response in kidney cancer - News-Medical</a><div class="link-content">May 6, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmRIcExKQ2hfa3BGUHlLRU1fa3hIdDJwS3V3U3VwRk90WWdmZ28zMllRUDIzalJ3eVpBajdrLXBnQXRsQXJ5dXlXMjBIUURjRzV3ZnBJbkVZcXhpY3lXalAxTV9Cem9yOU05RWxCMTREZXRjaHB2LUZORkw4Rk5WUzFtNUV1TEhRTVZzeTgwQkVsZ0ZUeFV5UHRWdDI0OEE?oc=5" class="headline-link">Consistent Safety Data Support Teclistamab/Daratumuamb in Myeloma - Targeted Oncology</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPak9JWVBqX3NINS1MWVJzV2JlZWM3cjhadjBwbTlvVnd2bkpFMGpadkpteUkwWDZmdzFlSVBhT2VmeEU0bUk3OENFLUhYZThfQW9zWGhaLXkwaDRZMU96U1IyR2lQcWNFeWZMdVVVRFBrWW14bDVWMkpsZUhLS0NTekxydVliZw?oc=5" class="headline-link">Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients - University of Miami</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPSGpwODd5YmZNaGc0aW83c2RURTZaU05CbzR3R3d6YV9keW5NWTZxYjZUcWJwLXE5dW5JWDZ2eUpNVXgtbVNKLUtTOTJ4YUlOS1JOdjlVNENsZUd6WGV5ci10dmlTMXhNYnpIWXVDU2ozbzgzaWtwY20xN0ktekc0akFxRlVzdw?oc=5" class="headline-link">IMNN-001: A Broader Approach to Immunotherapy - Targeted Oncology</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUjBRb3ZuUFR0amVnWmoweXhLdXFFTUF5al9nNGVWaWJhYmxpUFE1U2lrclZxMGtPb1lzTkROVFh0eGlsQnhEQ0N3amZPa0I5N2hTN0pOMnlXenN4c3UwWno1ekQwTGt6SV9jTWFzbzlCb1pwY0F3dWlFdUVkY2txQTEwZ0pqYzN3MjdzakJnbzc2d0RlRzgwdTRVMVd5MmxSTUdKcTVHTjFTdw?oc=5" class="headline-link">Iopofosine I 131 Shows Durable Responses in Waldenström Macroglobulinemia - Targeted Oncology</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQVXp5aC1vVlNyQXhJZlE4Skk4Q1FFQUN6d0JGMlpLSTRyTUNWeG1Qc0hrcTktSlVZVEhQSXoyXy1WVEowOEwwLVhMMVlKVFpRRUhUQ2lMMjZJSm01eTI3WkdvTzJsV0Q1SWxicGlQTTRYRFdfN3JzRGo4MllQNmtMaEtIU3RzUnZxUV92QXlpYXJFX1BkRXVDY01TMlR3MnNrVGhFUDVqakdIZFhDcGV2RmJNdC1pd2VVZnBVNWFCYVFhcHcyc1Blajc1S242N1dWeGREbDNMbFM1X3owLVlfQ2t3?oc=5" class="headline-link">Valion Bio Names Melinda Lackey General Counsel as It Advances Immunotherapy Pipeline and Regulatory Strategy - citybiz</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE50ZTM0aGN5bzVTb004dE5qSDRyZ0dCbHNpWTUtWHVPM0VWMjYzWEVSWWphaThPS204Rzg0LW1jZWRJbVdkNVdaU1lVRmdodjZrTkNZTlI1OV93Zw?oc=5" class="headline-link">Keytruda: New cancer jab available for patients at three health trusts - BBC</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE8xTF92SmZlNGlTb19sblBIZ2lZd3hRWjNoS3hLM0hMRXV1YXJVbEtHQktPQ3RUM0dKbFZDbXhGVVF5R0ZsRFBIU1k1Qm5zdTJNZm1OZmtxWjhnVlE?oc=5" class="headline-link">Yan Leyfman: Redefining What’s Biologically Possible in Pancreatic Cancer - Oncodaily</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1uTk5GVWFHc3c5UEcwSlhFb2diSklLVnB5cGkzdVo1YUdLZFFtTzVTSWg5TFRrb2JiR1VrX2lTUHZ0aldCRFpvcG5yaWZEQ1ZxeUQxazBZdURvRE1CZjZHa2dpRkpyTng3MGFRdGpXaw?oc=5" class="headline-link">$83M to Unlock a New Generation of Cancer Immunotherapies – Cytospire Therapeutics Ltd - Oncodaily</a><div class="link-content">May 5, 2026</div></li> <li class="the-content"> <a href="https://news.google.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?oc=5" class="headline-link">Intralesional Immunotherapy Effective Against Precancerous Oral Lesions, Suggests Study - Medical Dialogues</a><div class="link-content">May 5, 2026</div></li> </ul> </div></div><div class="widget-box drudge_col_posts" id="drudge-column-posts-3"><div class="wpd-posted-links"><h2 class="widget-head">Immunotherapy News from China</h2><ul class="posts-list posted-links-category-7"><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/08/09/update-2-u-s-fda-approves-merck-immunotherapy-chemo-combo-2/" class="headline-link">UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/07/13/announces-off-the-shelf-car-t-cell-cancer-immunotherapy-to/" class="headline-link">…Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/07/12/update-2-u-s-fda-approves-merck-immunotherapy-chemo-combo/" class="headline-link">UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/07/09/in-combination-with-anti-pd-l1-cancer-immunotherapy-and/" class="headline-link">…in Combination With Anti-PD-L1 Cancer Immunotherapy and …</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/07/03/dosed-in-first-in-human-clinical-study-of-immunotherapy/" class="headline-link">…Dosed in First-in-Human Clinical Study of Immunotherapy …</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/06/29/jitc-tumor-and-cancer-immunotherapy-papers-collection/" class="headline-link">JITC tumor and cancer immunotherapy papers collection</a><div class="image-wrap link-list-image" style="width: 200px"><a href="https://immunotherapytoday.com/2018/06/29/jitc-tumor-and-cancer-immunotherapy-papers-collection/"> <img src="https://immunotherapytoday.com/wp-content/uploads/2018/06/wgmVu1-300x200.jpg" alt="JITC tumor and cancer immunotherapy papers collection" width="200"></a></div></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/06/21/welcome-to-the-submissionjournal-for-immunotherapy-of-cancer/" class="headline-link">Welcome to the submission|Journal for ImmunoTherapy of Cancer</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/06/17/immunotherapy-shows-promise-for-advanced-lymphoma-study/" class="headline-link">Immunotherapy shows promise for advanced lymphoma: study</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/06/15/from-the-monotherapy-arm-at-the-phacilitate-immunotherapy/" class="headline-link">…from the Monotherapy Arm at the Phacilitate Immunotherapy …</a></li><li class="cf the-content"><a href="https://immunotherapytoday.com/2018/06/15/allergy-immunotherapy-market-to-exceed-us-3-33-bn-by-2025/" class="headline-link">Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …</a></li><li class="cf load-more-link"><p><a href="https://immunotherapytoday.com/category/baidu/" class="load-more" data-append-to="drudge-column-posts-3" data-none-left="Nothing to display ..." data-post-cat="7" data-nonce="cefc000a42" data-post-not-in="13072" data-offset="10">Load more [+]</a></p></li></ul></div></div> </div> <div class="clear"></div> </div> </div>  <div id="footer" class="site-footer"> Copyright 2018 ImmunoTherapyToday.com </div> </div>   <script type='text/javascript' id='contact-form-7-js-extra'> /* <![CDATA[ */ var wpcf7 = {"apiSettings":{"root":"https:\/\/immunotherapytoday.com\/wp-json\/contact-form-7\/v1","namespace":"contact-form-7\/v1"},"cached":"1"}; /* ]]> */ </script> <script type='text/javascript' src='https://immunotherapytoday.com/wp-content/plugins/contact-form-7/includes/js/scripts.js?ver=5.2.2' id='contact-form-7-js'></script> <script type='text/javascript' id='wpdrudge-main-js-extra'> /* <![CDATA[ */ var wpdrudgeAjaxScript = {"ajaxurl":"https:\/\/immunotherapytoday.com\/wp-admin\/admin-ajax.php"}; /* ]]> */ </script> <script type='text/javascript' src='https://immunotherapytoday.com/wp-content/themes/wp-drudge-v2.8.2/js/main.js?ver=2.8.2' id='wpdrudge-main-js'></script> <script type='text/javascript' src='https://immunotherapytoday.com/wp-includes/js/wp-embed.min.js?ver=5.5.13' id='wp-embed-js'></script> </body> </html>